King Charles III cancer: treatment scaled back in 2026
Buckingham Palace announced in 2026 that King Charles III's cancer treatment is being scaled back after he 'responded exceptionally well.' Care is moving into a precautionary phase; the palace has not confirmed full remission. Charles was diagnosed with cancer in early 2024. He remains active as monarch. Sources: NBC News, Buckingham Palace.
The context
King Charles III, who was diagnosed with cancer in early 2024, has been making encouraging progress. In 2026, Buckingham Palace announced that his treatment has been significantly scaled back after he “responded exceptionally well” to the programme of care he has undergone over the past two years. Doctors have transitioned his care from active treatment to a “precautionary phase”, a step that represents a meaningful improvement, though the palace has carefully avoided using the word remission.
Charles, now 77, has maintained his full schedule of royal duties throughout his illness. He hosted a state visit by US President Donald Trump in late April 2026, carrying out ceremonial and diplomatic functions as head of state. Buckingham Palace has consistently emphasised that Charles wishes to continue serving as monarch and that his medical team is encouraged by his trajectory.
The 2024 diagnosis came at an unusually public moment: the palace announced the cancer just weeks after a separate procedure for an enlarged prostate, and the two conditions were treated in parallel. The cancer type has never been officially specified by the palace, though media reports have suggested it is a form of blood cancer. Charles is the oldest person ever to accede to the British throne, having become King in September 2022 at the age of 73. His son William, Prince of Wales, remains heir apparent.